Does BLINATUMOMAB Cause Dysarthria? 55 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Dysarthria have been filed in association with BLINATUMOMAB (BLINCYTO). This represents 0.6% of all adverse event reports for BLINATUMOMAB.
55
Reports of Dysarthria with BLINATUMOMAB
0.6%
of all BLINATUMOMAB reports
4
Deaths
45
Hospitalizations
How Dangerous Is Dysarthria From BLINATUMOMAB?
Of the 55 reports, 4 (7.3%) resulted in death, 45 (81.8%) required hospitalization, and 6 (10.9%) were considered life-threatening.
Is Dysarthria Listed in the Official Label?
Yes, Dysarthria is listed as a known adverse reaction in the official FDA drug label for BLINATUMOMAB.
What Other Side Effects Does BLINATUMOMAB Cause?
Pyrexia (1,064)
Acute lymphocytic leukaemia recurrent (977)
Cytokine release syndrome (952)
Off label use (590)
Death (588)
Neurotoxicity (530)
Drug ineffective (345)
Headache (335)
Neutropenia (265)
Febrile neutropenia (262)
What Other Drugs Cause Dysarthria?
OLANZAPINE (900)
QUETIAPINE (669)
PREGABALIN (618)
AMLODIPINE (553)
GABAPENTIN (548)
METFORMIN (540)
METHOTREXATE (536)
DIAZEPAM (512)
ASPIRIN (495)
LORAZEPAM (483)
Which BLINATUMOMAB Alternatives Have Lower Dysarthria Risk?
BLINATUMOMAB vs BLONANSERIN
BLINATUMOMAB vs --BLOOD-COAGULATION FACTOR VIII FUSION PROTEIN WITH IMMUNOGLOBULIN G1 , ,-BIS WITH IMMUNOGLOBULIN G1
BLINATUMOMAB vs BOCEPREVIR
BLINATUMOMAB vs BOCOCIZUMAB
BLINATUMOMAB vs BONIVA